<\/p>\n
NEW FILINGS<\/p>\n
Company: Wanda Sports Group Company Limited
\nSymbol: WSG
\nDescription: They are a global sports events, media and marketing platform with significant intellectual property rights, long-term relationships and broad execution capabilities through which we create value for stakeholders in all parts of the sports ecosystem, from rights owners, to brands and advertisers, and to fans and athletes.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Deutsche Bank, Citigroup
\nCo-Manager(s): Haitong International, CICC, CLSA
\nFiled: 6-7-19
\nListed Cash Raise: $500m<\/p>\n
TERMS ADDED<\/p>\n
Company: Morphic Holding, Inc.
\nSymbol: MORF
\nDescription: They are a biopharmaceutical company applying our proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small-molecule integrin therapeutics.
\nShares: 5 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Thursday, 6\/27
\nTerms Added: 6-14-19<\/p>\n
Company: Change Healthcare Inc.
\nSymbol: CHNG
\nDescription: They are a leading independent healthcare technology platform that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
\nShares: 42.8 million
\nPrice Range: $16.00-$19.00
\nTrade Date: Thursday, 6\/27
\nUnderwriter(s): Barclays, Goldman Sachs, JP Morgan
\nTerms Added: 6-14-19<\/p>\n
Company: Linx S.A.
\nSymbol: LINX
\nDescription: They are a leading cloud-based technology company in Latin America and a market leader in Brazil in terms of revenue.
\nShares: 29.3 million
\nPrice Range: $8.68-$8.68
\nTrade Date: Wednesday, 6\/26
\nUnderwriter(s): Goldman Sachs, JP Morgan, Jefferies, BofA Merrill Lynch, Itau BBA
\nTerms Added: 6-13-19
\nCommon Shares Listed on Novo Mercado segment of the B3 S.A<\/p>\n
Company: Cambium Networks, Inc
\nSymbol: CMBM
\nDescription: They provide wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises and government agencies.
\nShares: 5.8 million
\nPrice Range: $13.00-$15.00
\nTrade Date: Wednesday, 6\/26
\nUnderwriter(s): JP Morgan, Goldman Sachs
\nCo-Manager(s): Deutsche Bank, Raymond James, JMP Securities, Oppenheimer
\nTerms Added: 6-13-19<\/p>\n
Company: Dermavant Sciences, Inc.
\nSymbol: DRMT
\nDescription: They are a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology.
\nShares: 7.7 million
\nPrice Range: $12.00-$14.00
\nMarket Cap: $295m-$345m
\nTrade Date: Thursday, 6\/20
\nUnderwriter(s): Jefferies, SVB Leerink, Guggenheim Securities
\nTerms Added: 6-10-19<\/p>\n
Company: Grocery Outlet Holding Corp.
\nSymbol: GO
\nDescription: They are a high-growth, extreme value retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores.
\nShares: 17.2 million
\nPrice Range: $15.00-$17.00
\nTrade Date: Thursday, 6\/20
\nUnderwriter(s): BofA Merrill Lynch, Morgan Stanley, Deutsche Bank, Jefferies, Barclays, Goldman Sachs, Guggenheim Securities, UBS Investment Bank, Cowen
\nCo-Manager(s): Telsey Advisory Group, Drexel Hamilton, Penserra Securities LLC
\nTerms Added: 6-10-19<\/p>\n
Company: Prevail Therapeutics Inc.
\nSymbol: PRVL
\nDescription: They are a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases.
\nShares: 7.35 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $545m-$612m
\nTrade Date: Thursday, 6\/20
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen
\nCo-Manager(s): Wedbush PacGrow
\nTerms Added: 6-10-19<\/p>\n
Company: Atreca Inc
\nSymbol: BCEL
\nDescription: They are a biopharmaceutical company utilizing our differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.
\nShares: 7.35 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $430m-$480m
\nTrade Date: Thursday, 6\/20
\nUnderwriter(s): Cowen, Evercore ISI, Stifel
\nCo-Manager(s): Canaccord Genuity, Brookline Capital
\nTerms Added: 6-10-19<\/p>\n
Company: Akero Therapeutics
\nSymbol: AKRO
\nDescription: They are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need.
\nShares: 5 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $370m-$420m
\nTrade Date: Thursday, 6\/20
\nUnderwriter(s): JP Morgan, Jefferies, Evercore ISI
\nCo-Manager(s): Roth Capital
\nTerms Added: 6-10-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-8652","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=8652"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8652\/revisions"}],"predecessor-version":[{"id":8653,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8652\/revisions\/8653"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=8652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=8652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=8652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}